financetom
Business
financetom
/
Business
/
Bank of Nova Scotia Price Targets Maintained at TD, CIBC Following Q3 Results
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Bank of Nova Scotia Price Targets Maintained at TD, CIBC Following Q3 Results
Aug 26, 2025 6:00 AM

08:33 AM EDT, 08/26/2025 (MT Newswires) -- Bank of Nova Scotia ( BNS ) reported third quarter results before market open on Tuesday.

TD Securities analyst Mario Mendonca said BNS beat EPS estimates significantly, primarily due to lower PCLs and "very strong" trading revenue.

"NIM was strong on lower funding costs, a key driver for BNS," Mendonca said in a note to clients.

"Credit remained favourable as impaired PCLs declined q/q and performing PCLs dropped materially as expected," the analyst said.

"CET1 was slightly better than expected, supporting the NCIB (3.2 Million share in quarter). We view this quarter favourably."

Mendonca maintained a Buy rating and $87 price target on BNS.

CIBC Capital Markets analyst Paul Holden said the results are "positive."

He maintained a Neutral rating and $90 price target on the stock.

"BNS reported a 9% beat relative to consensus and 6% relative to our estimate. Mostly a beat on higher trading revenue and lower PCLs," Holden said in a note to clients.

(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www.mtnewswires.com/contact-us)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Cisco Systems Unusual Options Activity For July 17
Cisco Systems Unusual Options Activity For July 17
Jul 17, 2024
Deep-pocketed investors have adopted a bullish approach towards Cisco Systems ( CSCO ) , and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in CSCO usually suggests something big is about to happen. We gleaned this information...
Campaigners urge UK government to block Shein's London IPO
Campaigners urge UK government to block Shein's London IPO
Jul 17, 2024
LONDON, July 17 (Reuters) - A new campaign backed by British retail consultant and television personality Mary Portas has launched an online petition calling on the new Labour government to block fast fashion retailer Shein from listing its shares in London. China-founded Shein, known for its $5 tops and $10 dresses, confidentially filed papers with Britain's markets regulator early last...
MGM Resorts International's BetMGM Launches Mobile Sports Betting in Washington DC
MGM Resorts International's BetMGM Launches Mobile Sports Betting in Washington DC
Jul 17, 2024
02:48 PM EDT, 07/17/2024 (MT Newswires) -- MGM Resorts International's ( MGM ) sports betting and gaming entertainment affiliate BetMGM launched its mobile sports betting operations on Wednesday across Washington DC. Sport fans all over the district now have access to BetMGM sports wagering, according to the company. BetMGM said the launch came after DC Council approved its fiscal year...
Adverum Releases Interim Data From Gene Therapy Study For Blindness Disorder, Prepares For Pivotal Study
Adverum Releases Interim Data From Gene Therapy Study For Blindness Disorder, Prepares For Pivotal Study
Jul 17, 2024
Adverum Biotechnologies Inc ( ADVM ) released data from its ongoing LUNA Phase 2 trial for Ixo-vec in patients with wet age-related macular degeneration (AMD). The 26-week interim analysis was presented at the American Society of Retinal Specialists Annual Meeting. Adverum is developing ixoberogene soroparvovec (Ixo-vec, formerly ADVM-022), its clinical-stage gene therapy product candidate, for wet AMD. In February, Adverum...
Copyright 2023-2026 - www.financetom.com All Rights Reserved